Longtime drug developer Suma Krishnan was 51 when she cofounded Krystal Biotech. Now the company has one gene therapy on the market and more in the works.
By Amy Feldman, Forbes Staff
Longtime drug developer Suma Krishnan was in her late-40s…
How A 60-Year-Old Drug Developer Built $4.4 Billion Krystal Biotech To Treat ‘Butterfly Skin Disease’
